Ad is loading...
OPT
Price
$3.17
Change
-$0.00 (-0.00%)
Updated
Nov 25 closing price
One day until earnings call
QLGN
Price
$4.78
Change
-$0.05 (-1.04%)
Updated
Nov 25 closing price
Ad is loading...

OPT vs QLGN

Header iconOPT vs QLGN Comparison
Open Charts OPT vs QLGNBanner chart's image
Opthea
Price$3.17
Change-$0.00 (-0.00%)
Volume$11.62K
CapitalizationN/A
Qualigen Therapeutics
Price$4.78
Change-$0.05 (-1.04%)
Volume$174.26K
CapitalizationN/A
OPT vs QLGN Comparison Chart
Loading...
OPT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
QLGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
OPT vs. QLGN commentary
Nov 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OPT is a Buy and QLGN is a StrongBuy.

COMPARISON
Comparison
Nov 26, 2024
Stock price -- (OPT: $3.16 vs. QLGN: $4.78)
Brand notoriety: OPT and QLGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OPT: 32% vs. QLGN: 81%
Market capitalization -- OPT: $491.07M vs. QLGN: $3.52M
OPT [@Biotechnology] is valued at $491.07M. QLGN’s [@Biotechnology] market capitalization is $3.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $468.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OPT’s FA Score shows that 0 FA rating(s) are green whileQLGN’s FA Score has 1 green FA rating(s).

  • OPT’s FA Score: 0 green, 5 red.
  • QLGN’s FA Score: 1 green, 4 red.
According to our system of comparison, QLGN is a better buy in the long-term than OPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OPT’s TA Score shows that 4 TA indicator(s) are bullish while QLGN’s TA Score has 5 bullish TA indicator(s).

  • OPT’s TA Score: 4 bullish, 5 bearish.
  • QLGN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, QLGN is a better buy in the short-term than OPT.

Price Growth

OPT (@Biotechnology) experienced а -2.91% price change this week, while QLGN (@Biotechnology) price change was +31.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.76%. For the same industry, the average monthly price growth was -2.17%, and the average quarterly price growth was +8.74%.

Reported Earning Dates

OPT is expected to report earnings on Feb 26, 2025.

QLGN is expected to report earnings on Mar 01, 2023.

Industries' Descriptions

@Biotechnology (+3.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OPT($491M) has a higher market cap than QLGN($3.52M). OPT YTD gains are higher at: 7.288 vs. QLGN (-82.615). QLGN has higher annual earnings (EBITDA): -6.73M vs. OPT (-199.29M). OPT has more cash in the bank: 172M vs. QLGN (388K). QLGN has less debt than OPT: QLGN (1.43M) vs OPT (142M). OPT has higher revenues than QLGN: OPT (125K) vs QLGN (0).
OPTQLGNOPT / QLGN
Capitalization491M3.52M13,945%
EBITDA-199.29M-6.73M2,961%
Gain YTD7.288-82.615-9%
P/E RatioN/A0.00-
Revenue125K0-
Total Cash172M388K44,330%
Total Debt142M1.43M9,902%
FUNDAMENTALS RATINGS
OPT vs QLGN: Fundamental Ratings
OPT
QLGN
OUTLOOK RATING
1..100
521
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5997
P/E GROWTH RATING
1..100
10039
SEASONALITY SCORE
1..100
31n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QLGN's Valuation (28) in the null industry is somewhat better than the same rating for OPT (88). This means that QLGN’s stock grew somewhat faster than OPT’s over the last 12 months.

QLGN's Profit vs Risk Rating (100) in the null industry is in the same range as OPT (100). This means that QLGN’s stock grew similarly to OPT’s over the last 12 months.

QLGN's SMR Rating (100) in the null industry is in the same range as OPT (100). This means that QLGN’s stock grew similarly to OPT’s over the last 12 months.

OPT's Price Growth Rating (59) in the null industry is somewhat better than the same rating for QLGN (97). This means that OPT’s stock grew somewhat faster than QLGN’s over the last 12 months.

QLGN's P/E Growth Rating (39) in the null industry is somewhat better than the same rating for OPT (100). This means that QLGN’s stock grew somewhat faster than OPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OPTQLGN
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 6 days ago
82%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 12 days ago
84%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
OPT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
QLGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KRMD3.660.14
+3.98%
KORU Medical Systems
LAUR19.710.19
+0.97%
Laureate Education
BALY17.770.04
+0.23%
Bally's Corp
NIO4.67-0.17
-3.51%
NIO Inc.
LGHL0.19-0.01
-4.17%
Lion Group Holding Ltd

OPT and

Correlation & Price change

A.I.dvisor tells us that OPT and QLGN have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OPT and QLGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPT
1D Price
Change %
OPT100%
+0.16%
QLGN - OPT
25%
Poorly correlated
-1.04%
GANX - OPT
25%
Poorly correlated
+5.81%
GRCE - OPT
25%
Poorly correlated
+4.88%
LBPH - OPT
24%
Poorly correlated
+0.18%
RANI - OPT
24%
Poorly correlated
N/A
More

QLGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, QLGN has been loosely correlated with VERU. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if QLGN jumps, then VERU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QLGN
1D Price
Change %
QLGN100%
-1.04%
VERU - QLGN
34%
Loosely correlated
+1.61%
PHIO - QLGN
32%
Poorly correlated
-0.81%
MRNS - QLGN
29%
Poorly correlated
-0.37%
ZLDAF - QLGN
29%
Poorly correlated
N/A
MNOV - QLGN
28%
Poorly correlated
-3.76%
More